{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:18:36Z","timestamp":1786119516904,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1097\/icu.0b013e32833cd40b","type":"journal-article","created":{"date-parts":[[2010,7,15]],"date-time":"2010-07-15T09:08:37Z","timestamp":1279184917000},"page":"329-334","source":"Crossref","is-referenced-by-count":33,"title":["Update on retinopathy of prematurity: treatment options and outcomes"],"prefix":"10.1097","volume":"21","author":[{"given":"Jonathan H","family":"Salvin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon S","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy H","family":"Hendricks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210206","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3928\/01913913-20070701-04","article-title":"Causes of visual impairment in children: a study of 3,210 cases","volume":"44","author":"Haddad","year":"2007","journal-title":"J Pediatric Ophthalmol Strabismus"},{"key":"R3-3-20210206","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The International Classification of Retinopathy of Prematurity Revisited.","volume":"123","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R4-3-20210206","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archopht.1988.01060130517027","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity.","volume":"106","year":"1988","journal-title":"Arch Ophthalmol"},{"key":"R5-3-20210206","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for treatment of retinopathy of prematurity: results of the Early Treatment for Retinopathy of Prematurity Randomized Trial.","volume":"121","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R6-3-20210206","first-page":"572","article-title":"Ophthalmology, American Academy of Pediatrics, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity.","volume":"117","year":"2006","journal-title":"Pediatrics"},{"key":"R7-3-20210206","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ajo.2008.05.010","article-title":"Progression and timing of treatment of zone I retinopathy of prematurity","volume":"146","author":"Soh","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R8-3-20210206","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaapos.2006.09.005","article-title":"The factor of time in retinopathy of prematurity","volume":"10","author":"Palmer","year":"2006","journal-title":"J AAPOS"},{"key":"R9-3-20210206","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archopht.123.3.311","article-title":"15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity","volume":"123","author":"Palmer","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R10-3-20210206","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0161-6420(01)01017-X","article-title":"A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years. Part 1: Visual function and structural outcome","volume":"109","author":"Ng","year":"2002","journal-title":"Ophthalmology"},{"key":"R11-3-20210206","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0161-6420(01)01015-6","article-title":"A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years. Part 2: Refractive outcome","volume":"109","author":"Connolly","year":"2002","journal-title":"Ophthalmology"},{"key":"R12-3-20210206","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/IAE.0b013e318169faee","article-title":"Diode laser treatment of retinopathy of prematurity: anatomic and refractive outcomes","volume":"28","author":"Axer-Siegel","year":"2008","journal-title":"Retina"},{"key":"R13-3-20210206","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jaapos.2009.09.018","article-title":"Transscleral diode laser retinal photocoagulation for the treatment of threshold retinopathy of prematurity","volume":"13","author":"Parvaresh","year":"2009","journal-title":"J AAPOS"},{"key":"R14-3-20210206","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaapos.2004.10.007","article-title":"Case Series of angle-closure glaucoma after laser treatment for retinopathy of prematurity","volume":"9","author":"Trigler","year":"2005","journal-title":"J AAPOS"},{"key":"R15-3-20210206","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ophtha.2007.08.050","article-title":"Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity","volume":"115","author":"Sonmez","year":"2008","journal-title":"Ophthalmology"},{"key":"R16-3-20210206","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.ophtha.2009.04.026","article-title":"Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity","volume":"116","author":"Sato","year":"2009","journal-title":"Ophthalmology"},{"key":"R17-3-20210206","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/ICU.0b013e3282f0ca54","article-title":"Antivascular endothelial growth factor therapy for ocular neovascular disease","volume":"18","author":"Andreoli","year":"2007","journal-title":"Curr Opin Ophthalmol"},{"key":"R18-3-20210206","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archophthalmol.2008.1","article-title":"Intravitreous Bevacizumab as antivascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study","volume":"126","author":"Kong","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"R19-3-20210206","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/IAE.0b013e3181a3b848","article-title":"Concentration of vascular endothelial growth factor in aqueous humor of eyes with advanced retinopathy of prematurity before and after intravitreal injection of bevacizumab","volume":"29","author":"Nonobe","year":"2009","journal-title":"Retina"},{"key":"R20-3-20210206","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ajo.2009.05.031","article-title":"A systematic analysis of the off-label use of bevacizumab for severe retinopathy of prematurity","volume":"148","author":"Micieli","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"R21-3-20210206","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/bjo.2008.156208","article-title":"Promise and potential pitfalls of anti-VEGF drugs in retinopathy of prematurity","volume":"93","author":"Darlow","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"R23-3-20210206","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1006\/mvre.2002.2426","article-title":"Erythropoietin and VEGF exhibit equal angiogenic potential","volume":"64","author":"Jaquet","year":"2002","journal-title":"Microvasc Res"},{"key":"R24-3-20210206","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaapos.2007.08.009","article-title":"Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model","volume":"12","author":"Suk","year":"2008","journal-title":"J AAPOS"},{"key":"R25-3-20210206","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-0029-1224872","article-title":"The effect of recombinant human erythropoietin on the development of retinopathy of prematurity","volume":"27","author":"Shah","year":"2010","journal-title":"Am J Perinatol"},{"key":"R26-3-20210206","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3928\/0191-3913-20070301-10","article-title":"Effect of diode laser ablative therapy for threshold retinopathy of prematurity on the visual field: results of Goldmann perimetry at a mean age of 11 years","volume":"44","author":"McLoone","year":"2007","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"R27-3-20210206","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jpeds.2008.05.018","article-title":"Maturation of rod function in preterm infants with and without retinopathy of prematurity","volume":"153","author":"Hamilton","year":"2008","journal-title":"J Pediatr"},{"key":"R28-3-20210206","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archopht.124.6.766","article-title":"Prevalence and course of strabismus in the first year of life for infants with prethreshold retinopathy of prematurity","volume":"124","author":"Vanderveen","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"R29-3-20210206","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.ophtha.2007.07.028","article-title":"Progression of myopia and high myopia in early treatment for retinopathy of prematurity study: findings to 3 years of age","volume":"115","author":"Quinn","year":"2008","journal-title":"Ophthalmology"},{"key":"R30-3-20210206","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.ajo.2008.01.026","article-title":"Myopia in adults with retinopathy of prematurity","volume":"145","author":"Baker","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R31-3-20210206","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ophtha.2008.09.035","article-title":"Astigmatism in the early treatment for retinopathy of prematurity study","volume":"116","author":"Davitt","year":"2009","journal-title":"Ophthalmology"},{"key":"R32-3-20210206","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jaapos.2007.08.012","article-title":"Long-term follow-up of visual functions in prematurely born children: a prospective population-based study up to 10 years of age","volume":"12","author":"Holmstrom","year":"2008","journal-title":"J AAPOS"},{"key":"R33-3-20210206","first-page":"225","article-title":"Retinopathy of prematurity: late complications in the baby boomer generation (1946\u20131964)","volume":"103","author":"Smith","year":"2005","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R34-3-20210206","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ajo.2007.11.007","article-title":"Adult retinopathy of prematurity: retinal complications from cataract surgery","volume":"145","author":"Kaiser","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R35-3-20210206","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jaapos.2008.10.014","article-title":"Cost-utility analysis of screening and laser treatment of retinopathy of prematurity","volume":"13","author":"Dunbar","year":"2009","journal-title":"J AAPOS"}],"container-title":["Current Opinion in Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/ICU.0b013e32833cd40b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:25:19Z","timestamp":1786040719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00055735-201009000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/icu.0b013e32833cd40b","relation":{},"ISSN":["1040-8738"],"issn-type":[{"value":"1040-8738","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}